Whitehawk Therapeutics (WHWK) Retained Earnings (2010 - 2026)
Whitehawk Therapeutics (WHWK) reported Retained Earnings of -$375.4 million for Q1 2026, down 44.59% year-over-year from -$677.4 million in Q1 2025, and down 312933.33% quarter-over-quarter from $120000.0 in Q4 2025.
Whitehawk Therapeutics (WHWK) Retained Earnings (2010 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 17 years of Retained Earnings data on file, last reported at -$375.4 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$375.4 million, down 44.59% year-over-year; the trailing twelve-month figure through Mar 2026 was -$375.4 million (down 44.59% YoY), and the FY2025 annual result was $120000.0, up 650.0% from the prior year.
- Retained Earnings retreated to -$375.4 million in Q1 2026 per WHWK's latest filing, from $120000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $120000.0 in Q4 2025 and troughed at -$375.4 million in Q1 2026.
- A 5-year average of -$214.4 million and a median of -$252.7 million in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings plunged 685888.64% in 2024, then soared 650.0% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$203.2 million in 2022, then sank by 32.36% to -$269.0 million in 2023, then surged by 100.01% to $16000.0 in 2024, then soared by 650.0% to $120000.0 in 2025, then plunged by 312933.33% to -$375.4 million in 2026.
- Business Quant data shows WHWK's Retained Earnings at -$375.4 million in Q1 2026, $120000.0 in Q4 2025, and -$330.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - | -375.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -375.40 Mn |
| Dec 31, 2025 | 120,000.00 |
| Sep 30, 2025 | -330.00 Mn |
| Jun 30, 2025 | -312.30 Mn |
| Mar 31, 2025 | -259.64 Mn |
| Dec 31, 2024 | 16,000.00 |
| Sep 30, 2024 | -314.40 Mn |
| Jun 30, 2024 | -301.84 Mn |
| Mar 31, 2024 | -287.30 Mn |
| Dec 31, 2023 | -268.96 Mn |
| Sep 30, 2023 | -252.70 Mn |
| Jun 30, 2023 | -44,000.00 |
| Mar 31, 2023 | -218.40 Mn |
| Dec 31, 2022 | -203.20 Mn |
| Sep 30, 2022 | -189.29 Mn |
| Jun 30, 2022 | -174.80 Mn |
| Mar 31, 2022 | -156.54 Mn |
| Dec 31, 2021 | -142.69 Mn |
| Sep 30, 2021 | -126.70 Mn |
| Jun 30, 2021 | -155.40 Mn |